Globus Medical (GMED) Net Income towards Common Stockholders (2011 - 2026)

Globus Medical (GMED) has 16 years of Net Income towards Common Stockholders data on file, last reported at $124.3 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 64.72% year-over-year to $124.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $586.7 million (up 216.18% YoY) and the FY2025 annual result came in at $537.9 million, up 422.28% from the prior year.
• Net Income towards Common Stockholders eased to $124.3 million in Q1 2026, from $140.6 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $202.8 million in Q2 2025 to a low of -$7.2 million in Q1 2024.
• A 5-year average of $62.1 million and a median of $49.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• The widest YoY moves for Net Income towards Common Stockholders: up 5093.99% in 2024, down 114.57% in 2024.
• Tracing GMED's Net Income towards Common Stockholders over 5 years: stood at $27.7 million in 2022, then slumped by 45.79% to $15.0 million in 2023, then soared by 76.3% to $26.5 million in 2024, then soared by 430.44% to $140.6 million in 2025, then slipped by 11.59% to $124.3 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $124.3 million (Q1 2026), $140.6 million (Q4 2025), and $119.0 million (Q3 2025), per Business Quant data.